Drug Repositioning Using Temporal Trajectories of Accompanying Comorbidities in Diabetes Mellitus

BACKGROUND: Most studies of systematic drug repositioning have used drug-oriented data such as chemical structures, gene expression patterns, and adverse effect profiles. As it is often difficult to prove repositioning candidates’ effectiveness in real-world clinical settings, we used patient-center...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Namgi, Jeon, Ja Young, Jeong, Eugene, Kim, Soyeon, Yoon, Dukyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901955/
https://www.ncbi.nlm.nih.gov/pubmed/35144331
http://dx.doi.org/10.3803/EnM.2021.1275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901955/
https://www.ncbi.nlm.nih.gov/pubmed/35144331
http://dx.doi.org/10.3803/EnM.2021.1275

Ejemplares similares